Meds Apotek AB (publ) (FRA:24R) Long-Term Debt: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:24R Meds Apotek AB (publ) FRA:24R
11 GF Score
Price €2.13
! 2 Warning Signs
View Full Analysis

What is Meds Apotek AB (publ) Long-Term Debt?

Meds Apotek AB (publ) FRA:24R +17.68% 11 Long-Term Debt is €0.00 Mil as of Jun. 2026. GuruFocus rates FRA:24R with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Meds Apotek AB (publ)'s Long-Term Debt for the quarter that ended in Jun. 2026 was €0.00 Mil.

Meds Apotek AB (publ)'s annual Long-Term Debt declined from Dec. 2023 (€2.09 Mil) to Dec. 2024 (€0.00 Mil) but then stayed the same from Dec. 2024 (€0.00 Mil) to Dec. 2025 (€0.00 Mil).

Meds Apotek AB (publ)  (FRA:24R) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Meds Apotek AB (publ) Long-Term Debt Related Terms

Meds Apotek AB (publ) Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Meds Apotek AB (publ)'s Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meds Apotek AB (publ) Long-Term Debt Chart

Meds Apotek AB (publ) Annual Data
Trend Dec21 Dec23 Dec24 Dec25
Long-Term Debt
0.00 2.09 0.00 0.00

Meds Apotek AB (publ) Quarterly Data
Dec21 Jun22 Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:24R
11GF Score
Meds Apotek AB (publ) FRA:24R
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €0.00 Mil mean?
Meds Apotek AB (publ) (FRA:24R) has a Long-Term Debt of €0.00 Mil as of Jun. 2026.
Is Meds Apotek AB (publ)'s Long-Term Debt too high?
Meds Apotek AB (publ)'s current Long-Term Debt is €0.00 Mil. Overall, Meds Apotek AB (publ) has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Meds Apotek AB (publ)'s Long-Term Debt compare to AMZN and BABA?
Meds Apotek AB (publ)'s Long-Term Debt of €0.00 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Retail - Cyclical company?
A good Long-Term Debt depends on the Retail - Cyclical industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Meds Apotek AB (publ)'s current Long-Term Debt is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meds Apotek AB (publ) stock overvalued right now?
Meds Apotek AB (publ) (FRA:24R) has a current Long-Term Debt of €0.00 Mil. The current Long-Term Debt is €0.00 Mil. Meds Apotek AB (publ)'s overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Meds Apotek AB (publ) (FRA:24R), the current Long-Term Debt is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Meds Apotek AB (publ) Business Description

Other Exchanges MEDS:Sweden
Address Elektravagen 26, Port 136, Hagersten, Stockholm, SWE, 12630
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
11GF Score

Get the complete analysis for FRA:24R

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.13
Price